Clover Biopharmaceuticals, Ltd.
HKEX:2197.HK
0.218 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -138.539 | -2,451.903 | -6,016.303 | -912.898 | -48.583 |
| Depreciation & Amortization
| 74.742 | 60.094 | 25.389 | 5.784 | 2.397 |
| Deferred Income Tax
| 0 | 0 | 65.899 | 0 | 0 |
| Stock Based Compensation
| 53.515 | 95.023 | 125.214 | 0 | 0 |
| Change In Working Capital
| -2,493.865 | 56.634 | 1,077.088 | 751.507 | 18.566 |
| Accounts Receivables
| -24.106 | 0 | 0 | 0 | 0 |
| Inventory
| -8.697 | -2,090.396 | -771.654 | -50.488 | -0.393 |
| Accounts Payables
| 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 73.014 | 2,147.03 | 1,848.742 | 801.995 | 18.959 |
| Other Non Cash Items
| 2.605 | 549.343 | 3,804.964 | 632.534 | 1.003 |
| Operating Cash Flow
| -727.878 | -1,690.809 | -917.749 | 476.927 | -26.617 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -9.176 | -105.56 | -80.316 | -113.792 | -6.816 |
| Acquisitions Net
| 0 | 0 | 21.064 | 0 | 0 |
| Purchases Of Investments
| 0 | -13.929 | -30 | -280.328 | 0 |
| Sales Maturities Of Investments
| 3.015 | 79.782 | 222.44 | 0 | 0 |
| Other Investing Activites
| 0.791 | 2.201 | -21.064 | -280.506 | 4.218 |
| Investing Cash Flow
| -6.161 | -37.506 | 112.124 | -394.12 | -2.598 |
| Financing Activities: | |||||
| Debt Repayment
| -16.201 | -28.773 | -14.735 | -4.472 | -1.726 |
| Common Stock Issued
| 0.084 | 453.155 | 1,750.029 | -0.327 | 0 |
| Common Stock Repurchased
| 0 | 0 | -530.179 | 0 | 0 |
| Dividends Paid
| 0 | 0 | -100.59 | 0 | 0 |
| Other Financing Activities
| -113.517 | 58.761 | 1,952.648 | 321.646 | 143.776 |
| Financing Cash Flow
| -142.408 | 483.143 | 3,057.173 | 316.847 | 142.05 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 4.902 | 85.21 | -0.361 | -32.164 | 0.115 |
| Net Change In Cash
| -871.545 | -1,159.962 | 2,251.187 | 367.49 | 112.95 |
| Cash At End Of Period
| 735.864 | 1,607.409 | 2,767.371 | 516.184 | 148.694 |